GlassScriptPhysician profile
Erika Galvin
NPI 1437471000
$1,071.67
in general payments reported to CMS, 2019-2025
9 companies · $585 in 2025
The $585 reported for 2025 was more than what 97% of Nurse Anesthetist, Certified Registered providers received nationally (typical 2025 total: $45.72).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $14.29 · 2023: $116 · 2024: $357 · 2025: $585.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,057.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,057.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $539.75 | 2024-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $219.75 | 2023-2025 | Entyvio |
| Regeneron Healthcare Solutions, INC. | $122.63 | 2022-2024 | Dupixent |
| Qol Medical, LLC | $65.94 | 2025 | Sucraid |
| Madrigal Pharmaceuticals | $27.95 | 2025 | Rezdiffra |
| Genzyme Corporation | $27.94 | 2023 | |
| Ardelyx, INC. | $26.60 | 2024 | Ibsrela |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.51 | 2025 | Xifaxan |
| Intercept Pharmaceuticals, INC. | $16.60 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erika Galvin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.